Lv6
2320 积分 2021-06-16 加入
抗体偶联药物关键组分解析: 抗体、载荷与连接子的发展脉络
1天前
已完结
The present and future of bispecific antibodies for cancer therapy
1天前
已完结
抗体偶联药物关键组分解析: 抗体、载荷与连接子的发展脉络
2天前
已完结
国家卫生健康委员会中国结直肠癌诊疗规范（2025版）（精简版）
5天前
已完结
LIBRETTO-432, a Phase III Study of Adjuvant Selpercatinib or Placebo in Stage IB-IIIA RET Fusion-Positive Non-Small-Cell Lung Cancer
21天前
已完结
Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases
1个月前
已完结
Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study
1个月前
已完结
Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study
1个月前
已完结
Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741
1个月前
已完结
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
1个月前
已完结
皖公网安备34019202002308
